Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Surg Res ; 178(1): 424-30, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22445456

ABSTRACT

BACKGROUND: We assessed the effects of dexmedetomidine in a rat model of α-naphthylthiourea (ANTU)-induced acute lung injury. METHODS: Forty Wistar Albino male rats weighing 200-240 g were divided into 5 groups (n = 8 each), including a control group. Thus, there were one ANTU group and three dexmedetomidine groups (10-, 50-, and 100-µg/kg treatment groups), plus a control group. The control group provided the normal base values. The rats in the ANTU group were given 10 mg/kg of ANTU intraperitoneally and the three treatment groups received 10, 50, or 100 µg/kg of dexmedetomidine intraperitoneally 30 min before ANTU application. The rat body weight (BW), pleural effusion (PE), and lung weight (LW) of each group were measured 4 h after ANTU administration. The histopathologic changes were evaluated using hematoxylin-eosin staining. RESULTS: The mean PE, LW, LW/BW, and PE/BW measurements in the ANTU group were significantly greater than in the control groups and all dexmedetomidine treatment groups (P < 0.05). There were also significant decreases in the mean PE, LW, LW/BW and PE/BW values in the dexmedetomidine 50-µg/kg group compared with those in the ANTU group (P < 0.01). The inflammation, hemorrhage, and edema scores in the ANTU group were significantly greater than those in the control or dexmedetomidine 50-µg/kg group (P < 0.01). CONCLUSION: Dexmedetomidine treatment has demonstrated a potential benefit by preventing ANTU-induced acute lung injury in an experimental rat model. Dexmedetomidine could have a potential protective effect on acute lung injury in intensive care patients.


Subject(s)
Acute Lung Injury/drug therapy , Dexmedetomidine/pharmacology , Pulmonary Edema/drug therapy , Thiourea/analogs & derivatives , Acute Lung Injury/chemically induced , Adrenergic alpha-2 Receptor Agonists/pharmacology , Animals , Disease Models, Animal , Drug Interactions , Lung/drug effects , Male , Pleural Effusion/chemically induced , Pleural Effusion/drug therapy , Pneumonia/chemically induced , Pneumonia/drug therapy , Pulmonary Edema/chemically induced , Rats , Rats, Wistar , Rodenticides/toxicity , Thiourea/toxicity
2.
Kaohsiung J Med Sci ; 28(1): 16-22, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22226057

ABSTRACT

Intestinal ischemia/reperfusion (I/R) is a complex phenomenon that causes destruction of both local and remote tissues. The objective of this study was to investigate the possible participation of oxidized low-density lipoproteins (oxLDLs) and inducible nitric oxide synthase (iNOS) expression in renal tissue damage after intestinal I/R. The superior mesenteric artery was blocked for 30 minutes, followed by 24 hours of reperfusion. At the end of the reperfusion period, renal tissues were removed; the presence of oxLDL, superoxide dismutase enzyme activity, malondialdehyde levels, and iNOS expression were evaluated. I/R resulted in positive oxLDL staining in renal tissue. Compared with control rats, tissue from the I/R group showed significantly higher malondialdehyde levels and lower superoxide dismutase enzyme activity. Strong and diffuse iNOS expression was present in the I/R group. Our findings support the hypothesis that I/R of intestinal tissue results in oxidative and nitrosative stress and enhances lipid peroxidation in the end organ. These data show that oxLDL accumulates in rat renal tissue after intestinal I/R. Antioxidant strategies may provide organ protection in patients with reperfusion injury, at least by affecting interactions with free radicals, nitric oxide, and oxLDL. This study demonstrates for the first time that oxLDL may play a role in renal tissue damage after intestinal I/R. Antioxidant strategies may be beneficial for protection from reperfusion injury.


Subject(s)
Intestines/blood supply , Kidney/enzymology , Kidney/pathology , Lipoproteins, LDL/metabolism , Nitric Oxide Synthase Type II/metabolism , Reperfusion Injury/enzymology , Reperfusion Injury/pathology , Animals , Female , Fluorescent Antibody Technique , Male , Malondialdehyde/metabolism , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism
3.
J Surg Res ; 157(1): e47-54, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19482302

ABSTRACT

BACKGROUND: Intestinal ischemia/reperfusion (I/R) is a complex phenomenon causing destruction of both local and remote tissues, as well as multiple-organ failure. We investigated the role of lipid peroxidation in damage to intestinal, liver, and lung tissues in this pathology. MATERIALS AND METHODS: The superior mesenteric artery was blocked for 30 min followed by 24 h of reperfusion. Tissues were removed and the presence of oxidized LDL, the activities of the superoxide dismutase enzyme, malondialdehyde levels, and inducible nitric oxide synthase expression were each evaluated in the intestinal, liver, and lung tissues. RESULTS: While there was no staining in the control group tissues, ischemia/reperfusion resulted in positive oxidized LDL staining in all of the I/R test group tissue samples. Inducible nitric oxide synthase expression was significantly increased in the ischemia/reperfusion group tissues. Compared with those of the control group rats, the ischemia/reperfusion group tissues showed significantly higher malondialdehyde levels and lower superoxide dismutase activities. CONCLUSIONS: This study demonstrated for the first time that oxidized LDL accumulated in the terminal ileum, liver, and lung tissues after intestinal ischemia/reperfusion. This occurrence (or the presence of oxidized LDL) may be an indicator of ongoing oxidative stress and enhanced lipid peroxidation. Augmentation of inducible nitric oxide synthase expression may play a role in progression of inflammation and LDL oxidation. These data support the hypothesis that cellular oxidative stress is a critical step in reperfusion-mediated injury in both the intestine and end organs, and that antioxidant strategies may provide organ protection in patients with reperfusion injury, at least through affecting interaction with free radicals, nitric oxide, and oxidized LDL.


Subject(s)
Ileum/metabolism , Lipoproteins, LDL/metabolism , Mesenteric Vascular Occlusion/metabolism , Reperfusion Injury/metabolism , Animals , Female , Ileum/blood supply , Ileum/pathology , Lipid Peroxidation/physiology , Liver/metabolism , Lung/metabolism , Male , Malondialdehyde/metabolism , Mesenteric Artery, Superior , Mesenteric Vascular Occlusion/pathology , Nitric Oxide Synthase Type II/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/pathology , Superoxide Dismutase/metabolism
4.
Mediators Inflamm ; 2007: 78454, 2007.
Article in English | MEDLINE | ID: mdl-17497039

ABSTRACT

BACKGROUND: Psoriasis is a chronic inflammatory skin disease characterized by an accelerated turnover of epidermal cells and an incomplete differentiation in epidermis with lesion. However, the exact etiology of psoriasis is unknown. Abnormalities in essential fatty acid metabolism, free radical generation, lipid peroxidation, and release of lymphokines have been proposed. OBJECTIVE: Our purpose was to evaluate the plasma lipids and oxidized low-density lipoprotein accumulation in psoriatic skin lesion in order to ascertain the possible participation of oxidative stress and oxidative modification of lipids in pathogenesis of psoriasis. METHODS: The study group included 84 patients with psoriasis, and 40 sex- and age-matched healthy volunteers. Blood lipid profile was determined. Psoriatic and nonlesional skin samples of psoriatic patients were evaluated for the presence of oxidized low-density lipoprotein by using an immune-fluorescent staining method. RESULTS: The mean levels of lipids (total cholesterol, triglyceride, and LDL cholesterol) in patients with psoriasis were found to be significantly higher than those of healthy subjects. Psoriatic skins were shown positive oxidized low-density lipoprotein staining. There was no staining in nonlesional skin samples of the same individuals. CONCLUSION: Lipid peroxidation mediated by free radicals is believed to be one of the important causes of cell membrane destruction and cell damage. This study shows for the first time the accumulation of oxidized low-density lipoprotein in psoriatic skin lesion. We believe that accumulation of ox-LDL in psoriatic skin may have an important role in the immune-inflammatory events that result in progressive skin damage.


Subject(s)
Lipids/blood , Lipoproteins, LDL/metabolism , Psoriasis/blood , Skin/metabolism , Adolescent , Adult , Cholesterol/blood , Cholesterol, LDL/blood , Female , Humans , Lipid Peroxidation , Male , Middle Aged , Prospective Studies , Skin/pathology , Triglycerides/blood
5.
Eur J Pharmacol ; 511(2-3): 183-9, 2005 Mar 28.
Article in English | MEDLINE | ID: mdl-15792787

ABSTRACT

This study was designed to investigate the possible participation of morphine in pulmonary oedema induced by alpha-naphthylthiourea (ANTU), which is a well-known noxious chemical agent in the lung. Injection of ANTU (15 mg/kg i.p.) produced pulmonary oedema as indicated by an increase in lung weight/body weight ratio and pleural effusion reaching a maximum within 4 h in rat. Administration of morphine prior to ANTU significantly inhibited to pulmonary oedema with a dose-dependent manner. The protective effect of morphine is prevented by peripheral opioid receptor antagonist, naloxone methiodide. ANTU-treated rats were shown positive by inducible nitric oxide synthase immunohistochemical staining. There was no staining in the control group. On the other hand, the degree of staining was markedly reduced in tissue sections by morphine. These results suggest that previous administration of subcutaneous morphine has preventive effect on ANTU-induced pulmonary inflammatory reaction and its effect mediated via peripheral opioid receptors. Application of naloxone with ANTU has no effect on the lung parameters indicating that endogenous opioids do not modulate ANTU-induced damage.


Subject(s)
Morphine/pharmacology , Naloxone/analogs & derivatives , Nitric Oxide Synthase/metabolism , Pulmonary Edema/prevention & control , Thiourea/analogs & derivatives , Animals , Dose-Response Relationship, Drug , Female , Immunohistochemistry , Lung/blood supply , Lung/drug effects , Lung/pathology , Male , Naloxone/pharmacology , Nitric Oxide Synthase Type II , Pulmonary Edema/chemically induced , Pulmonary Edema/enzymology , Quaternary Ammonium Compounds , Rats , Thiourea/toxicity
6.
Pharmacol Res ; 50(6): 585-91, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15501696

ABSTRACT

Oxidation of the low-density lipoprotein (LDL) results in the production of modified LDLs. Oxidation of LDL cholesterol plays a role on the pathogenesis of endothelial dysfunction. This study was designed to investigate the possible participation of the oxidative modification of low density lipoprotein in the lung edema induced by alpha-naphthylthiourea (ANTU), which is a well-known noxious chemical agent on the lung endothelium. When ANTU injected intraperitoneally into rats (15 mg kg(-1)), it produced lung edema as indicated by an increase in lung weight/body weight (LW/BW) ratio and pleural effusion (PE) reaching a maximum within 4 h. A significant lung edema was observed 4 h after intraperitoneally injection of alpha-naphthylthiourea when compared with olive oil-injected control rats. On microscopic examination of alpha-naphthylthiourea-treated rats were shown to have severe lung injury, while no change was observed in olive oil-treated control rats. While there were no staining in control lungs, positive oxidized low-density lipoproteins immune-fluorescent staining were observed in lung edema group. Our study showed that oxidized low-density lipoprotein (oxLDL) accumulated in ANTU-induced lung damage. This is the first study in which accumulation of oxLDL molecules in the intact lung tissue were shown by fluorescent immune-staining method in experimental lung edema. The potential role of oxLDL in this pathology are still under investigation.


Subject(s)
Lipoproteins, LDL/analysis , Lung/chemistry , Lung/pathology , Pulmonary Edema/chemically induced , Pulmonary Edema/pathology , Thiourea/analogs & derivatives , Thiourea/toxicity , Animals , Female , Lipoproteins, LDL/metabolism , Lung/metabolism , Male , Pulmonary Edema/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...